Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvant
Open Access
- 23 July 1998
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (4) , 209-215
- https://doi.org/10.1056/nejm199807233390401
Abstract
The risk of acquiring Lyme disease is high in areas in which the disease is endemic, and the development of a safe and effective vaccine is therefore important.Keywords
This publication has 31 references indexed in Scilit:
- Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adultsVaccine, 1996
- Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Cerebrospinal Fluid in Lyme NeuroborreliosisThe Journal of Infectious Diseases, 1996
- Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme DiseaseThe Journal of Infectious Diseases, 1995
- The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis.The Journal of Experimental Medicine, 1994
- Perspective on the development of vaccines against Lyme disease: Robert Edelman evaluates the current situationVaccine, 1991
- Rapid Emergence of a Focal Epidemic of Lyme Disease in Coastal MassachusettsNew England Journal of Medicine, 1989
- On sample sizes to estimate the protective efficacy of a vaccineStatistics in Medicine, 1988
- Longitudinal Assessment of the Clinical and Epidemiological Features of Lyme Disease in a Defined PopulationThe Journal of Infectious Diseases, 1986
- Incidence and Cumulative Frequency of Endemic Lyme Disease in a CommunityThe Journal of Infectious Diseases, 1984
- An epidemic of oligoarticular arthritis in children and adults in three connecticut communitiesArthritis & Rheumatism, 1977